Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Chinese Journal of Biotechnology ; (12): 1222-1233, 2019.
Artículo en Chino | WPRIM | ID: wpr-771806

RESUMEN

Sulfated compounds are widely present in cytoplasm, on cell surface, and in extracellular matrix. These compounds play important roles in cell development, differentiation, immune response, detoxication, and cell signal transduction. 3-Phosphoadenosine-5-phosphosulfate (PAPS) is the universal sulfate group donor for the biosynthesis of sulfated compounds. Up to now, the synthesis of PAPS is still too expensive for industrial applications. This review focuses on the recent progress of PAPS production and summaries the application of PAPS, particularly in the production of glucosinolate, heparin, condroitin sulfate, and oxamniquine production.


Asunto(s)
Diferenciación Celular , Sulfatos de Condroitina , Fosfoadenosina Fosfosulfato , Metabolismo , Sulfatos
2.
Mem. Inst. Oswaldo Cruz ; 108(7): 881-886, 1jan. 2013. tab
Artículo en Inglés | LILACS | ID: lil-696010

RESUMEN

Mice infected with Schistosoma mansoni were treated with oxamniquine, praziquantel, artesunate at the pre-patent phase, aiming at observing schistogram alterations. Half of the animals were perfused five days post-treatment for counting and classification of immature worms, based on pre-established morphological criteria (schistogram); the remaining animals were evaluated 42 or 100 days after infection and perfusion of the portal-system was performed for collection and counting of adult worms and oogram. It was observed that oxamniquine and artesunate treatment administered at the pre-postural phase causes significant reduction in the number of immature and adult worms. However, there was little reduction with praziquantel when used at the dose of 400 mg/kg for treatments administered 14, 15, 21 or 23 days post-infection. Artesunate was responsible for significant alterations in development of young worms, as well as for a higher number of worms presenting intestinal damages. Immature adult worms were detected in mice treated with artesunate or oxamniquine at the pre-patent phase of infection and recovered by perfusion 100 days after infection. Schistogram proved to be a very useful tool for experimental evaluation of the activity of antischistosomal drugs and a good model to identify the most sensitive stages to drugs.


Asunto(s)
Animales , Femenino , Ratones , Artemisininas/uso terapéutico , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/uso terapéutico , Quimioterapia Combinada/métodos , Oxamniquina/uso terapéutico , Recuento de Huevos de Parásitos , Parasitemia/tratamiento farmacológico , Praziquantel/uso terapéutico , Schistosoma mansoni/crecimiento & desarrollo
3.
Rev. Soc. Bras. Med. Trop ; 42(5): 581-582, Sept.-Oct. 2009. ilus
Artículo en Inglés | LILACS | ID: lil-532517

RESUMEN

The relationship between bladder tumors and Schistosoma haematobium is well known, but only sporadic cases of bladder infection due to Schistosoma mansoni have been reported. In this case, a 48-year-old woman with macroscopic hematuria, dysuria and a palpable abdominal mass was investigated. Ultrasound showed a large exophytic mass in the bladder. Transurethral resection of the bladder revealed viable eggs of Schistosoma mansoni. The patient was treated clinically with oxamniquine and surgery was performed to resect the large mass. This case shows that schistosomiasis Mansoni in the bladder can simulate bladder cancer.


É bem conhecida a relação entre tumor vesical e Schistosoma haematobium, porém somente casos esporádicos de infecção vesical por Schistosoma mansoni foram relatados. Neste caso, uma mulher de 48 anos com hematúria macroscópica, disúria e massa abdominal palpável foi investigada, ultra-sonografia mostrou uma grande massa exofítica na bexiga. A ressecção transuretral de bexiga evidenciou ovos viáveis de Schistosoma mansoni. A paciente foi tratada clinicamente com oxaminiquine e uma cirurgia foi realizada para ressecar a grande massa. Este caso mostra que a esquistossomose mansônica vesical pode simular um câncer vesical.


Asunto(s)
Animales , Femenino , Humanos , Persona de Mediana Edad , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis mansoni/diagnóstico , Enfermedades de la Vejiga Urinaria/parasitología , Diagnóstico Diferencial , Oxamniquina/uso terapéutico , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/uso terapéutico , Enfermedades de la Vejiga Urinaria/diagnóstico , Neoplasias de la Vejiga Urinaria/diagnóstico
4.
Mem. Inst. Oswaldo Cruz ; 84(supl.1): 38-45, 1989. tab
Artículo en Inglés | LILACS | ID: lil-623564

RESUMEN

Genetic crosses between phenotypically resistant and sensitive schistosomes demonstrated that resistance to hycanthone and oxamniquine behaves like a recessive trait, thus suggesting that resistance is due to the lack of some factor. We hypothesized that, in order to kill schistosomes, hycanthone and oxamniquine need to be converted into an active metabolite by some parasite enzyme wich, if inactive, results in drug resistance. Esterification of the drugs seemed to be the most likely event as it would lead to the production of an alkylating agent upon dissociation of the ester. An artificial ester of hycanthone was indeed active even in resistant worms, thus indirectly supporting our hypothesis. In addition, several lines of evidence demonstrated that exposure to hycanthone and oxamniquine results in alkylation of worm macromolecules. Thus, radioactive drugs formed covalent bonds with the DNA of sensitive (but not of resistant) schistosomes; an antiserum raised against hycanthone detected the presence of the drug in the purified DNA fraction of sensitive (but not of resistant) schistosomes; a drug-DNA adduct was isolated from hycanthone-treated worms and fully characterized as hycanthone-deoxyguanosine.


Asunto(s)
Animales , Cobayas , Ratones , Schistosoma mansoni/efectos de los fármacos , Resistencia a Medicamentos/genética , Hicantona/farmacología , Genes de Helminto , Cruzamientos Genéticos
5.
Rev. Soc. Bras. Med. Trop ; 16(4): 213-218, out.-dez. 1983. ilus, tab
Artículo en Portugués | LILACS | ID: lil-676348

RESUMEN

Foram tratados com oxamniquine 23 esquistossomóticos com forma hepatosplênica instalada há menos de seis anos. Eles permaneceram na área endêmica, se reinfectaram e foram revistos após 2-4 anos. Houve melhora na evolução da doença em 78,3%. A melhora variou da completa reversão da hepatosplenomegalia (26%) à simples diminuição da esplenomegalia com persistência ou não das lesões nodulares hepáticas. A resposta ao tratamento não foi influenciada pelo número de ovos de S. mansoni ms fezes e nem pela repetição do tratamento. Contudo, os pacientes com idade acima de nove anos responderam melhor ao tratamento. Na hipertensão porta esquistossomótica, pelo menos na ausência de hemorragias digestivas, o tratamento especifico deve preceder qualquer indicação cirúrgica.


Twenty three patients with a less than six year history of the hepatosplenic form of schistosomiasis were treated with oxamniquine. They remained in the endemic area, were reinfected and re-examined after 2-4 years. Improvement was noted in 78,3% of the patients. The recovery varied from complete reversion of the hepatosplenomegaly (26%) to a reduction of the splenomegaly with or without persistent hepatic nodular lesions. Response to the treatment was not influenced by the number of S. mansoni eggs in the feces nor by repetitions of the treatment. In schistosomiasis with portal hypertension, at least in theabsenceofdigestive hemorrhages, specific treatment must preceed any recommended surgery.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA